?? Check out our visual abstract investigating the results of a phase III study of tacrolimus against IVCY in patients with LN. ?? https://loom.ly/y9P6yF8 #lupus
Lupus Hub
在线教育
An online resource, dedicated to providing information and up-to-date medical education within the lupus space.
关于我们
- 网站
-
https://www.lupushub.com
Lupus Hub的外部链接
- 所属行业
- 在线教育
- 规模
- 11-50 人
- 类型
- 私人持股
动态
-
The Lupus Hub is an open-access online resource for a time-stretched HCP, dedicated to providing balanced, credible, and up-to-date medical education in #Lupus To find out more about us, visit our website: https://loom.ly/3ZMfn-w #MedEd
-
-
?? News ?? U.S. FDA accepts supplemental biologics license application for obinutuzumab for the treatment of #lupus nephritis based on results from the phase III REGENCY trial. The approval decision is expected by October 2025. https://loom.ly/gyk4yH8 #RheumTwitter #MedNews
-
-
?? News ?? U.S. FDA grants fast track designation to ADI-001, a CD20-directed allogeneic gamma delta CAR T-cell therapy, for the treatment of refractory #SLE with extrarenal involvement. Phase I patient enrollment is expected in Q1 2025. ?? https://loom.ly/87rJyUo #lupus #RheumTwitter #MedNews
-
-
?? NEWS ?? U.S. FDA clears IND application for ALLO-329, a dual-targeted CD19/CD70 allogeneic CAR-T, for #SLE, including #LupusNephritis and other autoimmune diseases. Phase I RESOLUTION basket trial is expected to begin mid-2025. ?? https://loom.ly/f2Vbwt4 #MedNews #RheumTwitter
-
-
?? The American College of Rheumatology 2024 guidelines provide expert guidance for the monitoring and treatment of #lupus nephritis. More news: https://lupushub.com/ #RheumTwitter #MedNews #MedEd
-
-
New guidelines ?? The American College of Rheumatology has provided evidence-based expert guidance for the management of #lupus nephritis in adults and children. Read more: https://loom.ly/eRVhkBI #RheumTwitter #LupusNephritis #MedNews #MedEd
-
-
Why sign up to the #Lupus Hub’s user account feature? ? Personalize your areas of interest ? Bookmark preferred content ? Receive tailored recommendations based on your areas of interest and recently read articles Create your account now: https://loom.ly/S9iQjIY
-